Graeme Currie
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Graeme Currie
The proxy statement of Pasithea Therapeutics Corp. reports total compensation of $444,864 for Graeme Currie in fiscal 2023, including a base salary of $330,647. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Pasithea Therapeutics Corp. (KTTA)
Proxy statement
Start not stated–2023-10-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pasithea Therapeutics Corp. (KTTA) | — | — | — |
| 2023 | Pasithea Therapeutics Corp. (KTTA) | Chief Development Officer | $330,647 | $444,864 |
| 2022 | Pasithea Therapeutics Corp. (KTTA) | Chief Development Officer | $143,870 | $198,870 |
Recent activity
No call appearances or filed executive changes recorded yet.